Active Cancer Biomarkers Grants

PI Name Organization - Company Titlesort ascending Major Program / Research Group FOA
Balu, Mihaela University Of California-Irvine Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma PAR-20-155: Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems
Meltzer, Stephen J Johns Hopkins University Facile screening for esophageal cancer in LMICs RFA-CA-15-024: Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UG3/UH3)
Godwin, Andrew K. University Of Kansas Medical Center Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem PA-21-071: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
Zhu, Yazhen University Of California Los Angeles Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma PAR-20-053: Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection
Wu, Yun State University Of New York At Buffalo Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection Innovative Technology Development for Cancer Research RFA-CA-18-002: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Wu, Yun State University Of New York At Buffalo Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detection PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Goel, Ajay Beckman Research Institute/City Of Hope Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer PAR-16-276: Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection
Lin, Daniel W. Fred Hutchinson Cancer Center Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance PAR-18-310: Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed)
Shi, Honglan Missouri University Of Science & Technology Establishing Biological Significance of Pteridine Metabolites in Progressive Breast Cancer PAR-18-021: NCI Small Grants Program for Cancer Research
Moormann, Ann M Univ Of Massachusetts Med Sch Worcester Enhancing racial and ethnic diversity inCOVID-19 research participation through storytelling (COVIDstory) COVID Serology RFA-CA-20-038: Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence
Zarrinpar, Amir University Of California, San Diego Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer RFA-CA-20-054: Collaborative Approaches to Engineer Biology for Cancer Applications
Wong, David T University Of California Los Angeles EFIRM-Liquid Biopsy (eLB): Ultrasensitive ctDNA and miRNA Detection for Early Assessment of Lung Cancer Liquid Biopsy Consortium RFA-CA-17-029: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment
Ivanov, Alexander R. Northeastern University Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detection PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Lee, Hakho Massachusetts General Hospital Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics Liquid Biopsy Consortium RFA-CA-17-029: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment
Genkinger, Jeanine M. Columbia University Health Sciences Early Detection of Ovarian Cancer Through Epigenetic Factors in the WHI PA-13-302: Research Project Grant